Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Authors
Keywords
-
Journal
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Volume 119, Issue -, Pages 110609
Publisher
Elsevier BV
Online
2022-07-22
DOI
10.1016/j.pnpbp.2022.110609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
- (2021) Adriana Feder et al. AMERICAN JOURNAL OF PSYCHIATRY
- Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study
- (2021) Adem T. Can et al. Translational Psychiatry
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
- (2021) Yan Wei et al. MOLECULAR PSYCHIATRY
- Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
- (2021) Felicia Ceban et al. CNS DRUGS
- Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
- (2021) Giovanni Martinotti et al. Brain Sciences
- Trends in Ketamine Use, Exposures, and Seizures in the United States up to 2019
- (2021) Joseph J. Palamar et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
- (2021) Johanna Louise Keeler et al. Nutrients
- Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
- (2021) Anya Ragnhildstveit et al. Frontiers in Psychiatry
- Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review
- (2020) Dimy Fluyau et al. DRUG AND ALCOHOL DEPENDENCE
- Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option
- (2020) Daniel F. Hermens et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
- (2020) Danilo De Gregorio et al. JOURNAL OF NEUROSCIENCE
- Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial
- (2020) Rebecca L Rothberg et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature
- (2019) Jasper Kamp et al. Expert Opinion on Drug Metabolism & Toxicology
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- The development of glutamate-based antidepressants is taking longer than expected
- (2018) Ricardo Garay et al. DRUG DISCOVERY TODAY
- A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study
- (2018) E. Dakwar et al. NEUROPHARMACOLOGY
- The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation?
- (2018) Chadi G. Abdallah et al. PHARMACOLOGY & THERAPEUTICS
- The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders
- (2017) M Kokkinou et al. MOLECULAR PSYCHIATRY
- Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
- (2017) Francesco Bartoli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Mechanism of NMDA Receptor Inhibition and Activation
- (2016) Shujia Zhu et al. CELL
- Ketamine: NMDA Receptors and Beyond
- (2016) C. F. Zorumski et al. JOURNAL OF NEUROSCIENCE
- Activation of NMDA receptors and the mechanism of inhibition by ifenprodil
- (2016) Nami Tajima et al. NATURE
- Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
- (2016) Kristian Gaarn du Jardin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior
- (2016) Faryal Mallick et al. Current Psychiatry Reports
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- Memantine ER/Donepezil: A Review in Alzheimer’s Disease
- (2015) Sarah L. Greig CNS DRUGS
- A structural biology perspective on NMDA receptor pharmacology and function
- (2015) Michael C Regan et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
- (2014) Le-Ben Wan et al. JOURNAL OF CLINICAL PSYCHIATRY
- GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
- (2014) Oliver H Miller et al. eLife
- N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease
- (2013) David Olivares et al. Current Alzheimer Research
- Ketamine use among regular tobacco and alcohol users as revealed by respondent-driven sampling in Taipei: Prevalence, expectancy, and users' risky decision making
- (2013) Wei J. Chen et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder
- (2011) Jordan R Covvey et al. ANNALS OF PHARMACOTHERAPY
- The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment
- (2011) Herbert Y. Meltzer et al. PSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders
- (2010) Thomas Insel et al. AMERICAN JOURNAL OF PSYCHIATRY
- Glutamate-based antidepressants: 20 years on
- (2009) Phil Skolnick et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started